Julian Moran, BSc
Rationale and design of the PIONEER PLUS study evaluating high dose oral GLP-1 receptor agonist therapy for the treatment of type 2 diabetes
Rationale and design of the PIONEER PLUS study evaluating high dose oral GLP-1 receptor agonist therapy for the treatment of type 2 diabetes
Development of Clostridioides Screening for Inflammatory Bowel Disease Patients
